Sentences with phrase «editing technology»

Though Longevity has a fairly limited number of portfolio companies thus far, one of them, the genome editing technology company Precision BioSciences, secured a partnership last month with food giant Cargill; the two are now working together on a new product to reduce saturated fat in canola oil.

Hell, low - cost video editing technology has been around for more than a couple of years — and the bandwidth is there.

The key to the monsters» growth spurts is a real - life DNA - editing technology currently under research.

Science magazine has unveiled its 2015 «Breakthrough of the Year» and the winner is a gene - editing technology that experts say will change life as we know it — potentially revolutionizing medicine, basic science, and agriculture.

The CRISPR / Cas9 genome - editing technology allows the rapid generation of genetically modified animals as well as controlled genetic modification in cell lines and primary cells.

While genome editing technology represents a highly promising area to advance the future of therapy for hematologic disorders, critical questions must be addressed to effectively translate this approach into clinical use.

PULLMAN, Wash. — A gene editing technology developed at Washington State University is being licensed to Genus plc, a global animal genetics company, to develop cattle that are more resistant to bovine respiratory disease (BRD).

As CRISPR - Cas9 starts to move into clinical trials, a new study published in Nature Methods has found that the gene - editing technology can introduce hundreds of unintended mutations into the... Read more

A life sciences patent expert has explained that this is largely down to improved knowledge of the gene - editing technology's wide - ranging potential applications, which means that it will be harder for future applicants to establish the non-obviousness of their CRISPR innovations.

CRISPR, a new gene editing technology that is derived from the immune systems of certain bacteria, allows researchers to alter genes with unprecedented accuracy.

To date, the program has brought three scientists from broad disciplines to the Institute to trigger innovation and collaboration in single - particle cryo - electron microscopy, three - dimensional genomic organization and the gene editing technology known as CRISPR.

To that end, Berkeley Lab researchers will use CRISPR / Cas9 gene - editing technology, which Berkeley Lab scientist Jennifer Doudna helped pioneer, to systematically test the function of representative sequences in mice.

They will use CRISPR genome - editing technology to correct or insert disease - causing mutations in experimental models, and screen for potential drug targets with the goal of correcting neuronal dysfunction caused by the mutations.

Genome editing technology enables precise modification of individual protein coding genes, as well as noncoding regulatory sequences, enabling the elucidation of functional effects in human disease relevant cellular systems.

NYSCF — Robertson Stem Cell Investigator and NYSCF — Robertson Stem Cell Prize recipient Feng Zhang, PhD, Core Member of the Broad Institute of Harvard and MIT, shared yet another novel update of CRISPR gene editing technology.

In the paper, the researchers discuss how recent breakthroughs in CRISPR - Cas9 gene editing technology coupled with their discovery last year of a male sex determining gene Nix could be a winning combination for tipping the male - female mosquito ratio in the wild.

CRISPR is a revolutionary gene - editing technology that has many potential applications in medicine.

The CRISPR gene - editing technology, which has swept the world, is a great example.

If you haven't already, find out more about why this gene - editing technology is a game - changer just by watching the video above.

A study led by Johan Elf (Uppsala University / SciLifeLab) have demonstrated how the Cas9 component of the CRISPR - Cas9 genome editing technology is able to find the right DNA sequence.

An excellent example of the use of CRISPR gene editing technology came up at the Emory - Children's Pediatric Research Center's Innovation Conference this week.

Gene editing technology, combined with iPSC generation and a clinically relevant differentiation strategy combine to offer a new treatment for a blood borne genetic disease

To confirm the role of SP5G, BTI Assistant Professor Joyce Van Eck used the gene editing technology CRISPR / Cas9 to create mutations in SP5G.

Using gene editing technology, the researchers demonstrated that they could rapidly create a quick - flowering tomato plant by altering one of the genes.

This gene editing technology continues to become more sophisticated, and several HD research teams are adapting it to the challenges of HD therapy.

Clustered regularly interspaced short palindromic repeats, also known as CRISPR, evokes a sense of unease in many people, especially since the term has become synonymous to gene editing technology.

CRISPR isn't the first gene - editing technology promising to cure thousands of diseases.

Gene editing technology CRISPR - Cas9 emerged as Science magazine's 2015 Breakthrough of the Year.

Currently, she is working at Dr. Church lab as a postdoc, further developing genome editing technology that she studied at her Ph. D.

Debate about so - called germline editing of eggs, sperm and embryos has been going on for decades, but it has come to a head in recent years with the development of a powerful new gene - editing technology called Crispr - Cas9 that can make extremely precise edits to DNA and which was used by the Chinese team and would be used by the British team.

In fewer than five years, a gene - editing technology known as CRISPR has revolutionized research.

With her recent groundbreaking findings in the field of RNA - mediated regulation based on the CRISPR - Cas9 system, E. Charpentier has laid the foundation for the development of a novel, highly versatile and specific genome editing technology that is revolutionizing life sciences research and could open up whole new opportunities in biomedical gene therapies.

The promise of new CRISPR gene - editing technology has always been that it might lead to a cure for specific genetic diseases.

Recently published findings from a team of researchers at the University of Massachusetts Medical School in Worcester, Mass., suggest that a modified form of this CRISPR gene - editing technology may eventually result in a cure for facioscapulohumeral muscular dystrophy (FSHD), a form of the disease that leads to progressive muscular degeneration in the face, shoulder blades and upper arms.

Using the gene editing technology (CRISPR / Cas9) in human embryos is unacceptable in the UK ethical framework, and I notice that in the Nature report, this paper was suggested to be rejected by journals potentially on ethical grounds.

When a team of Chinese scientists announced last spring that they had edited the genes of human embryos using the powerful new gene editing technology known as CRISPR / Cas9, the world suddenly discovered that the dystopian possibility of «designer babies» was no longer an unrealistic fantasy, but rather a technically achievable possibility that must be reckoned with.

One form of gene therapy involves the direct repair of a defective gene, using genome - editing technology such as CRISPR - Cas9.

This model is particularly amenable to gene editing technology, which makes it possible to design cells with specific disease - relevant mutations — a boon for those studying the cause and progression of metabolic diseases of the liver.

BERKELEY, Calif. — May 18, 2016 — Genus plc (LSE: GNS)(«Genus»), a global pioneer in animal genetics, and Caribou Biosciences, Inc. («Caribou»), a leader in the revolutionary field of CRISPR - Cas gene editing, are pleased to announce a multi-year strategic collaboration where Genus receives a worldwide, exclusive license to Caribou's leading CRISPR - Cas9 gene editing technology platform in certain livestock species.

If no ES cells or less than 3 clones are available within the IKMC consortium, only the constitutive knock - out model will be generated using CRISPR genome editing technology.

Dr. Doudna is being recognized for harnessing CRISPR - Cas systems to establish a transformative gene - editing technology platform.

Caribou and DuPont enter into multi-year research collaboration to advance genome editing technology platform

«We are hard at work trying to translate base editing technology into human therapeutics,» Liu says.

In the frame of this call, we have added constitutive knock - out models to be generated using CRISPR (clustered regularly interspaced short palindromic repeats) genome editing technology.

The credit for that likely goes to CRISPR, the powerful new genome - editing technology.

People around the world are working to use the latest DNA - editing technology, called CRISPR - Cas9, to fix the gene - based ails that plague so many victims.

Intellia is developing human gene and cell therapies for both ex vivo and in vivo applications using CRISPR - Cas9 gene editing technology.

Dr. Kanner brings more than 25 years of experience in drug discovery and development and will lead Caribou's research and development of new applications for its gene editing technology.

Their collaboration led to a seminal study from which resulted this so called «genome editing technology», which exploits the fact that the CRISPR system, which is present in S. pyogenes, uses Cas9 for interference.

Caribou's market - leading CRISPR - Cas9 gene editing technology can accurately target and cut DNA to produce precise and controllable changes to the genome, which can be applied by JAX to create mouse models that better recapitulate human diseases enabling researchers to find better treatments faster.